BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15788464)

  • 21. Happy with your care?
    Graham J; Denoual I; Cairns D
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):173-8. PubMed ID: 15788034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assertive outreach teams in London: patient characteristics and outcomes. Pan-London Assertive Outreach Study, part 3.
    Priebe S; Fakhoury W; Watts J; Bebbington P; Burns T; Johnson S; Muijen M; Ryrie I; White I; Wright C
    Br J Psychiatry; 2003 Aug; 183():148-54. PubMed ID: 12893668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance contracting for substance abuse treatment.
    Commons M; McGuire TG; Riordan MH
    Health Serv Res; 1997 Dec; 32(5):631-50. PubMed ID: 9402905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing an integrated substance use and mental health service in the specialised setting of a youth detention centre.
    Stathis SL; Letters P; Doolan I; Whittingham D
    Drug Alcohol Rev; 2006 Mar; 25(2):149-55. PubMed ID: 16627304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
    Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing integrated treatment for co-existing substance use and severe mental health problems in assertive outreach teams: training issues.
    Graham HL
    Drug Alcohol Rev; 2004 Dec; 23(4):463-70. PubMed ID: 15763751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study.
    McHugo GJ; Drake RE; Teague GB; Xie H
    Psychiatr Serv; 1999 Jun; 50(6):818-24. PubMed ID: 10375153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Planning Treatment and Assessing Recovery in Participants With Dual Diagnosis: Preliminary Evaluation of a New Clinical Tool.
    Noel V; Woods M; Routhier J; Drake R
    J Dual Diagn; 2016; 12(1):55-62. PubMed ID: 26828850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assertive outreach strategies for narrowing the adolescent substance abuse treatment gap: implications for research, practice, and policy.
    Ozechowski TJ; Waldron HB
    J Behav Health Serv Res; 2010 Jan; 37(1):40-63. PubMed ID: 18690540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting the views of substance misuse and mental health treatment providers on treating the dually diagnosed.
    Grella CE
    Subst Use Misuse; 2003 Aug; 38(10):1433-46. PubMed ID: 14509546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceptions of assertive community treatment in the UK and Lithuania.
    Tyrer P; Balod A; Germanavicius A; McDonald A; Varadan M; Thomas J
    Int J Soc Psychiatry; 2007 Nov; 53(6):498-506. PubMed ID: 18181352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severely and persistently mentally ill substance abusers: clinical and policy issues.
    Zweben JE
    J Psychoactive Drugs; 2000; 32(4):383-9. PubMed ID: 11210200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assertive outreach: an effective strategy for engaging homeless persons with substance use disorders into treatment.
    Fisk D; Rakfeldt J; McCormack E
    Am J Drug Alcohol Abuse; 2006; 32(3):479-86. PubMed ID: 16864475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assertive outreach teams in London: models of operation. Pan-London Assertive Outreach Study, part 1.
    Wright C; Burns T; James P; Billings J; Johnson S; Muijen M; Priebe S; Ryrie I; Watts J; White I
    Br J Psychiatry; 2003 Aug; 183():132-8. PubMed ID: 12893666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing standards of care for individuals with co-occurring psychiatric and substance use disorders.
    Minkoff K
    Psychiatr Serv; 2001 May; 52(5):597-9. PubMed ID: 11331791
    [No Abstract]   [Full Text] [Related]  

  • 36. Outreach care: a sensitive approach.
    Heath T; Nicholson G
    Nurs Times; 1999 Feb 3-9; 95(5):51-3. PubMed ID: 10095610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
    Lambert-Harris C; Saunders EC; McGovern MP; Xie H
    J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assertive outreach teams in London: staff experiences and perceptions. Pan-London Assertive Outreach Study, part 2.
    Billings J; Johnson S; Bebbington P; Greaves A; Priebe S; Muijen M; Ryrie I; Watts J; White I; Wright C
    Br J Psychiatry; 2003 Aug; 183():139-47. PubMed ID: 12893667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental health provider perspectives on co-occurring substance use among severely mentally ill clients.
    Mericle AA; Alvidrez J; Havassy BE
    J Psychoactive Drugs; 2007 Jun; 39(2):173-81. PubMed ID: 17703712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. North Birmingham assertive outreach evaluation. Patient characteristics and clinical outcomes.
    Commander M; Sashidharan S; Rana T; Ratnayake T
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):988-93. PubMed ID: 16341614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.